Cong Yu, MD
Anesthesiology · Seattle, WANPI 1457398158
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Nevro Corp. at 40.2% of the total. Reporting peaked in 2021 at $14,836 and has fallen 72.8% since, to $4,042 in 2025. Among anesthesiology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 376 payments — averaging $149.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$23K
- Boston Scientific$20K
- Medtronic$5K
- Saluda Medical Americas, Inc.$2K
- Si-bone, Inc.$1K
- Abbott$893
- plus $4K from 17 others
Across 126 payments — averaging $5224.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nevro Corp.$543K
- Globus Medical$55K
- Boston Scientific$34K
- Seikagaku Corporation$26K
What the payments were for
- Consulting fees$16,04428%
- Speaking & faculty fees$6,18511%
- Travel & lodging$8,65715%
- Food & beverage$25,49045%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 153 | $22,667 |
| Boston Scientific | 78 | $20,160 |
| Medtronic(2 entities) | 60 | $4,769 |
| Saluda Medical Americas, Inc. | 10 | $2,081 |
| Si-bone, Inc. | 7 | $1,315 |
| Abbott | 23 | $893 |
| Globus Medical | 11 | $564 |
| SPR Therapeutics, Inc | 4 | $482 |
| AbbVie | 4 | $440 |
| Painteq LLC | 4 | $431 |
| Vertos Medical, Inc. | 4 | $298 |
| Biotronik NRO, Inc. | 2 | $298 |
| Stimwave Technologies Incorporated | 2 | $272 |
| AstraZeneca | 2 | $260 |
| Nalu Medical, Inc. | 3 | $223 |
| Stryker | 2 | $207 |
| Stemline Therapeutics Inc. | 1 | $181 |
| Relievant Medsystems, Inc. | 1 | $173 |
| Seagen Inc. | 1 | $150 |
| Vertiflex, Inc. | 1 | $141 |
| Genentech, Inc. | 1 | $132 |
| Daiichi Sankyo Inc. | 1 | $125 |
| Amgen | 1 | $112 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$11,524
- GENERAL PAIN MANAGEMENT$8,406
- SPECTRA WAVEWRITER$7,540
- Senza$5,043
- Senza Spinal Cord Stimulation System$3,494
- Evoke$2,001
- INTELLIS ADAPTIVESTIM$1,957
- WaveWriter Alpha Prime 16$1,744
- KYPHON EXPRESS II KYPHOPAK TRAY$1,321
- IFUSE IMPLANT SYSTEM$1,114
- Intracept$799
- SPRINT PNS System$416
- GENERAL - THERAPIES$414
- PAINTEQ$384
- Proclaim IPG$302
- Prospera$298
- mild Device Kit$283
- Senza II$266
- SUPERION$251
- BOTOX$242
How this compares
$56,375 in reported general payments places this provider in the 95th percentile of 1,206 anesthesiology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 28 | $9,974 |
| Buprenorphine | 45 | $7,385 |
| Fentanyl | 60 | $7,362 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 23 | $3,558 |
| Morphine Sulfate ErMorphine Sulfate | 86 | $3,353 |
| Oxycodone Hcl | 169 | $2,867 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 93 | $2,280 |
| Pregabalin | 86 | $2,221 |
| Gabapentin | 100 | $1,244 |
| Tizanidine Hcl | 67 | $1,199 |
| Baclofen | 46 | $1,115 |
| Methadone Hcl | 20 | $631 |
| Buprenorphine Hcl | 27 | $580 |
| Duloxetine Hcl | 32 | $527 |
| Hydromorphone Hcl | 25 | $436 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Seattle
- David AuyongSeattle$284K
- Lucy HostetterSeattle$96K
- Georg MackensenSeattle$81K
- Ata-Ul RahmanSeattle$59K
- Deborah MerrillSeattle$37K
- David StoutSeattle$31K
- Wenyu PanSeattle$25K
- Nicholas KassebaumSeattle$23K
- Richard SheuSeattle$21K
- Srdjan JelacicSeattle$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.